newsfilter
← Latest News
GlobeNewswire·

Oyster Point Pharma to Present Analyses at the Women in Ophthalmology Summer Symposium

PRINCETON, N.J., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (NASDAQ:OYST), a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat op